Emerging targets in osteoporosis disease modification.
Allen
John G
JG
Chemistry Research and Discovery, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, USA. johallen@amgen.com
Fotsch
Christopher
C
Babij
Philip
P
D000818:Animals; D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000187:drug effects; D001862:Bone Resorption / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D010024:Osteoporosis / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism* / Q000503:physiopathology
D015415:Biomarkers